Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients

NCT00327249 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: imexon

Sponsor

AmpliMed Corporation